Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

BillionToOne Inc

BLLN ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Mid Cap Analyst: BUY

Last Close

$96.74

▲ +1.80%

Market Cap $4.56B · Vol 156.56K

Key Metrics

P/E Ratio

173.65

FWD: N/A

Market Cap

$4.56B

Mid Cap

Div Yield

N/A

EPS Growth

+465.31%

YoY

RSI (14)

25.82

Momentum

Beta

N/A

vs Market

52W High

$150.44

35.70% below

52W Low

$62.00

56.03% above

Volume

156.56K

Avg 201.42K

P/B

7.81

Price-to-book

ROE

0.50%

Return on equity

Free Float

58.73%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, BillionToOne Inc (BLLN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BLLN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.01%

-23.27%

+12.59%

+37.03%

YTD

+18.21%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$305.11M
Net Income	$7.45M
Revenue Growth (YoY)	N/A
Gross Margin	68.32%
Operating Margin	5.25%
Net Profit Margin	2.44%
ROE	0.50%
ROA · ROIC	1.66% · 1.96%

P/E Ratio	173.65
Forward P/E (FY1)	N/A
PEG Ratio	5.19
P/S	5.69
P/B	7.81
P/FCF	110.86
EPS Growth	+465.31%
Outstanding Shares	47.19M

Technical Indicators

50-Day SMA	$115.21
200-Day SMA	$N/A
RSI (14)	25.82
Beta	N/A
52-Week High	$150.44
52-Week Low	$62.00

Volume Today	156.56K
Avg Daily Volume (30D)	201.42K
Relative Volume	0.78x
Volatility (10D)	47.78
Volatility (30D)	150.10
Free Float	58.73%

Analyst Consensus

BUY

Current Price $96.74

Mean Target $118.00

52W Low$62.00 52W High$150.44

Current

Target

$62.00 $150.44

Current Analyst target

+21.98% upside potential · 8 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00NR7JXV7

ISINUS0901681058

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateDec 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -0.74% RVMD Revolution Medicines Inc +1.01% ONC BeOne Medicines AG -0.66% 068270.KS Celltrion Inc +0.88% ABVX Abivax SA +1.04%

Company Profile

BillionToOne, Inc. is a precision diagnostics company that quantifies biology to create molecular diagnostics. The Company's proprietary molecular counting platform is designed to detect and measure deoxyribonucleic acid (DNA) molecules at a single-count level to help improve disease detection. It applies the proprietary technology to non-invasive prenatal screening (Prenatal) and liquid biopsy (Oncology). Its Quantitative Counting Templates (QCTs), power its ability to detect and measure tiny and sparse disease-related DNA fragments, or molecules, at the single base-pair level. These include pregnancy-related DNA that code for recessively inherited conditions such as sickle cell disease and cystic fibrosis and ctDNA in the case of cancer. Its prenatal products include UNITY Complete, UNITY Fetal Risk Screen, UNITY Aneuploidy Screen, UNITY Fetal RhD NIPT, UNITY Fetal Antigen NIPT, and UNITY Fetal Antigen CTA NIPT. Its oncology products include Northstar and Northstar Select.